| Followers | 144 |
| Posts | 27611 |
| Boards Moderated | 3 |
| Alias Born | 02/07/2004 |
Thursday, December 14, 2023 10:28:36 AM
Q3 results, herewith the reply:
We have not publicly announced our Q3/23 earnings release date. Please follow our SEC filings for any public announcements: https://www.redhillbio.com/investors/financial-filings/sec-filings/default.aspx
Thank you and best regards,
Alexandra
Alexandra Okmian Sanderovich, Senior Business Development & Investor Relations Manager, RedHill Biopharma Ltd.
P: +972 3 541 3131 D: +972 3 639 8893 M: +972 53 71 71 476 F: +972 3 541 3144
E: alexandra@redhillbio.com, W: www.redhillbio.com
A very evasive reply if i ever saw one.
Recent RDHL News
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
